Leo Metz counsels private and public companies of all growth stages on various corporate matters, including venture capital financings, mergers and acquisitions, cross-border transactions, corporate governance, and public offerings.
Cooley advised Halcyon on its $100 million Series C funding. Partner Derek Colla led the Cooley team advising Halcyon, an organization devoted to defeating ransomware through prevention and resilience by way of a proprietary technology that captures encryption keys, enabling organizations to recover from attacks in minutes without paying ransom.
Cooley advised Lightning AI on its $50 million equity investment. Partner Derek Colla led the Cooley team advising Lightning AI, a company that simplifies and accelerates artificial intelligence development by providing a unified platform for training, deploying and scaling it.
Cooley advised Lightning AI, creator of the PyTorch Lightning framework, on its $50 million equity investment from Cisco Investments, J.P. Morgan, K5 Global and NVIDIA, bringing its total funding to $103 million.
Cooley advised Boldend, a top cyber automation company developing software solutions that enhance and scale cyber capabilities, on its acquisition by SIXGEN, a full-spectrum provider of cyber products, operations and solutions to the US national security and critical infrastructure sectors.
The Chapter 11 plan of PhaseBio Pharmaceuticals, a long-standing Cooley life sciences client, has gone effective following the court’s confirmation of the Chapter 11 plan on June 26, 2024. The plan provides for a global settlement with the official committee of unsecured creditors and a settlement with PhaseBio’s former co-development partner. The Chapter 11 bankruptcy case in the US Bankruptcy Court for the District of Delaware was handled by a multioffice, cross-disciplinary Cooley team.
